Literature DB >> 27336790

Phenotyping Adults with Non-Cystic Fibrosis Bronchiectasis: A 10-Year Cohort Study in a French Regional University Hospital Center.

Matthieu Buscot1, Héloïse Pottier, Charles-Hugo Marquette, Sylvie Leroy.   

Abstract

BACKGROUND: Data concerning phenotypes in bronchiectasis are scarce.
OBJECTIVE: The aim of this study was to describe the clinical, functional and microbiological phenotypes of patients with bronchiectasis.
METHODS: A monocentric retrospective study in a university hospital in France was conducted over 10 years (2002-2012). Non-cystic fibrosis patients with tomographic confirmation of bronchiectasis were included. The clinical, functional and microbiological data of patients were analyzed relying on the underlying etiology.
RESULTS: Of the 311 included patients, an etiology was found for 245 of them. At the time of diagnosis, the median age was 61 years and the mean FEV1 was 63% of predicted. The main causes of bronchiectasis were post-infectious (50%, mostly related to tuberculosis), chronic obstructive pulmonary disease (COPD; 13%) and idiopathic (11%). Other causes were immune deficiency (6%), asthma (4%), autoimmunity (3%), tumor (2%) and other causes (4%). The comparison of phenotypic traits shows significant differences between COPD, congenital and idiopathic groups in term of sex (p = 0.0175), tobacco status (p < 0.0001), FEV1 (p = 0.0412) and age at diagnosis (p < 0.001), Pseudomonas aeruginosa (PA) colonization (p = 0.0276) and lobectomy (0.0093). Functional follow-up was available in 30% of patients with a median duration of 2.7 years. Presence of PA was associated with a lower median FEV1 at diagnosis (43% p < 0.003) but not with a faster rate of decline in FEV1.
CONCLUSION: Distinctive clinical, functional and microbiological features were found for idiopathic, congenital and COPD-related bronchiectasis. A prospective follow-up of these subgroups is necessary to validate their relevance in the management of bacterial colonization and specific complications of these bronchiectases.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27336790     DOI: 10.1159/000446923

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  10 in total

Review 1.  The clinical phenotype of bronchiectasis and its clinical guiding implications.

Authors:  Li Gao; Ke-Ru Qin; Ting Li; Hai-Long Wang; Min Pang
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-26

2.  Adult Primary Antibody Deficiencies and the Lung.

Authors:  Ebru Damadoğlu
Journal:  Turk Thorac J       Date:  2021-05

3.  Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry.

Authors:  David De la Rosa; Miguel-Angel Martínez-Garcia; Rosa Maria Giron; Montserrat Vendrell; Casilda Olveira; Luis Borderias; Luis Maiz; Antoni Torres; Eva Martinez-Moragon; Olga Rajas; Francisco Casas; Rosa Cordovilla; Javier de Gracia
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 4.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

5.  Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center.

Authors:  Hélène Goussault; Hélène Salvator; Emilie Catherinot; Marie-Laure Chabi; Colas Tcherakian; Alexandre Chabrol; Morgane Didier; Elisabeth Rivaud; Alain Fischer; Felipe Suarez; Olivier Hermine; Fanny Lanternier; Olivier Lortholary; Nizar Mahlaoui; Philippe Devillier; Louis-Jean Couderc
Journal:  Respir Res       Date:  2019-12-04

6.  Evaluating hemoptysis hospitalizations among patients with bronchiectasis in the United States: a population-based cohort study.

Authors:  Rachel K Lim; Alain Tremblay; Shengjie Lu; Ranjani Somayaji
Journal:  BMC Pulm Med       Date:  2021-12-01       Impact factor: 3.317

7.  Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients.

Authors:  Stefano Aliberti; Francesco Amati; Andrea Gramegna; Barbara Vigone; Martina Oriano; Giovanni Sotgiu; Marco Mantero; Edoardo Simonetta; Laura Saderi; Anna Stainer; Serena Tammaro; Paola Marchisio; Eva Polverino; James D Chalmers; Francesco Blasi
Journal:  ERJ Open Res       Date:  2022-03-28

8.  Risk Factors Associated with Impairment in Pulmonary Diffusing Capacity among Patients with Noncystic Fibrosis Bronchiectasis.

Authors:  Kaijun Zhang; Xin Zou; Zhiyi Ma; Xiaohong Liu; Chencheng Qiu; Lingyan Xie; Zhaosheng Lin; Saiyu Li; Yongming Wu
Journal:  Can Respir J       Date:  2022-03-09       Impact factor: 2.409

9.  Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006-2021: a systematic review and meta-analysis.

Authors:  Yunchun Zhou; Wei Mu; Jihua Zhang; Shi Wu Wen; Smita Pakhale
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

Review 10.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.